// App-Quantinova.ai

: Efficacy of Mesenchymal Stromal Cells for Refractory Late-Onset Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell Transplantation

Researchers

Presenter

  • Ke Zhao

Principal Investigators

  • Zhiping Fan

  • Xiaoyong Chen

  • Yuan Chang

  • Li Xuan

  • Na Xu

  • Fen Huang

  • Pengcheng Shi

  • Ren Lin

  • Hui Liu

  • Jing Sun

  • Andy Peng Xiang

  • Qifa Liu

Medical Centers

  • Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China

  • Center for Stem Cell Biology and Tissue Engineering, Sun Yat-sen University, Guangzhou, China

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • Cytomegalovirus infection

Biomarkers

  • Mesenchymal stem cells

Drug/Treatment

  • Allopurinol

Outcome

  • N/A

Study Design

  • Efficacy

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved